Skip to main content
All Posts By

Brandon Allison

2019 Year In Review – An Overview Of Insights in Pharmaceutical Manufacturing, Clinical Research and Technology Articles

2019 Year In Review – An Overview Of Insights in Pharmaceutical Manufacturing, Clinical Research and Technology

How Pharma, CROs, and CDMOs can prepare for 2020 ISR conducted approximately two dozen individual pieces of market research for syndication in 2019. This webinar summarizes many of the important learnings from these projects, providing attendees with real, usable data…
Brandon Allison
Big Pharma CMOs win for Biologic API and Alcami Scores Highest for Biologic Drug Product Press

Big Pharma CMOs win for Biologic API and Alcami Scores Highest for Biologic Drug Product

ISR's latest Biologic API and Biologic Drug Product CDMO Benchmarking Reports have arrived Informing the pharmaceutical drug development, manufacturing and commercialization industry. Raleigh, NC – May 23, 2018 –Industry Standard Research’s (ISR’s) 3rd annual Biologic API Contract Manufacturer Quality Benchmarking…
Brandon Allison
FLAMMA, Novasep and Alcami Win for Small Molecule Contract Manufacturing Performance Press

FLAMMA, Novasep and Alcami Win for Small Molecule Contract Manufacturing Performance

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – May 15, 2018 –  Industry Standard Research's (ISR’s) annual Small Molecule API Contract Manufacturer Quality Benchmarking report reveals that FLAMMA and Novasep received the highest Overall Performance Scores based…
Brandon Allison
Respondents Average 3.2 Small Molecule Sterile Injectables in Their Development Pipelines Press

Respondents Average 3.2 Small Molecule Sterile Injectables in Their Development Pipelines

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – August 8, 2017 –  Industry Standard Research's (ISR's) Small Molecule Sterile Injectable Drug Product Manufacturing Market Overview and Outlook report looks specifically at the portfolios and pipelines of small molecule sterile…
Brandon Allison
Low cost continues to gain importance among both development and commercial small molecule outsourcers Press

Low cost continues to gain importance among both development and commercial small molecule outsourcers

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – July 25, 2017 –  Industry Standard Research's (ISR’s) Development vs Commercial Outsourced Manufacturing Practices: Small Molecule report offers insight into how the industry, using different outsourcing scenarios, prioritizes…
Brandon Allison
Development-stage drug product outsourcers highly value Right-first-time measurements Press

Development-stage drug product outsourcers highly value Right-first-time measurements

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – July 25, 2017 –  Industry Standard Research's (ISR’s) Development vs Commercial Outsourced Manufacturing Practices: Biologics report offers insight into how respondents in different outsourcing scenarios prioritize different CMO selection…
Brandon Allison
Traditional Tablets Will Lose Market Share Due to Increased Use of Modified Release Technologies Press

Traditional Tablets Will Lose Market Share Due to Increased Use of Modified Release Technologies

Informing the pharmaceutical drug development, manufacturing and commercialization industry. CARY, NC - May 31, 2017 - The 2nd edition of Industry Standard Research's (ISR's) Oral Dosage Forms Market Overview and Outlook report offers details on how industry utilization rates of seventeen different…
Brandon Allison
Celerion, SGS Life Sciences Stand-out Performers in ISR’s 2017 Phase I Quality Benchmarking Report Press

Celerion, SGS Life Sciences Stand-out Performers in ISR’s 2017 Phase I Quality Benchmarking Report

The Phase I CROs received high marks in organization and staff factors Informing the pharmaceutical drug development, manufacturing and commercialization industry. CARY, NC - May 18, 2017 - Industry Standard Research (ISR) has released a new report, CRO Quality Benchmarking - Phase I…
Brandon Allison
Big Pharma CMOs capture strongest performance ratings for small molecule API manufacturing Press

Big Pharma CMOs capture strongest performance ratings for small molecule API manufacturing

Manufacturers benefit from having innovators as their parent companies Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – February 9, 2017 – The 2nd edition of Industry Standard Research's (ISR’s) Small Molecule API Contract Manufacturer Quality Benchmarking report…
Brandon Allison
Regulatory history and reliable on-time delivery beat cost and capacity as the most important selection attributes for drug product CMOs Press

Regulatory history and reliable on-time delivery beat cost and capacity as the most important selection attributes for drug product CMOs

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – February 8, 2017 – The 2nd edition of Industry Standard Research’s (ISR’s) Drug Product Contract Manufacturer Quality Benchmarking report reveals that buyers of outsourced drug product manufacturing services…
Brandon Allison
Cell Line Selection Predicted to Shift to CMOs, Double Digit Increase in Demand for the Service Press

Cell Line Selection Predicted to Shift to CMOs, Double Digit Increase in Demand for the Service

New report defines which biologic manufacturing capabilities are needed Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – October 12, 2016 – A new report from Industry Standard Research (ISR), Bioprocessing Services and Technologies Market Trends and…
Brandon Allison
Sponsors and CROs Agree that Integrating Statistical Modeling and Knowledge of Past Performance into Feasibility Analyses Improves Accuracy of Results Press

Sponsors and CROs Agree that Integrating Statistical Modeling and Knowledge of Past Performance into Feasibility Analyses Improves Accuracy of Results

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – August 30, 2016 – A new report, Best Practices in Study Feasibility, from Industry Standard Research (ISR) reveals insights into how to successfully navigate many of the challenges—medical,…
Brandon Allison
New ISR Report Reveals Current and Future Dynamics in Phase II/III Market, Changes Expected in Clinical Trial Spend Press

New ISR Report Reveals Current and Future Dynamics in Phase II/III Market, Changes Expected in Clinical Trial Spend

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – June 21, 2016 – Industry Standard Research has released its comprehensive new report, “Phase II/III Study Trends and Market Outlook (2016-2020),” concerning the trends, resource allocation, and market…
Brandon Allison
One-Third of Cancer Patients Have a Genetic Profile Accessible by Their Oncologist Press

One-Third of Cancer Patients Have a Genetic Profile Accessible by Their Oncologist

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – May 24, 2016 – A new market research report titled Personalized Medicine’s Effect on Oncologists’ Treatment Regimens, from Industry Standard Research (ISR), finds that, according to US-based oncologists,…
Brandon Allison
Two-thirds of Biopharma Sponsors Surveyed Currently Sell or Plan to Sell Biosimilar Products Press

Two-thirds of Biopharma Sponsors Surveyed Currently Sell or Plan to Sell Biosimilar Products

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – May 17, 2016 – A new report titled Biosimilars Manufacturing: Key Considerations and Expected Outsourcing Practices (3rd edition), from Industry Standard Research (ISR), indicates that the majority of…
Brandon Allison
ISR’s New Report Provides Common Structures, Models for Pharma’s Regulatory Affairs Departments Press

ISR’s New Report Provides Common Structures, Models for Pharma’s Regulatory Affairs Departments

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – March 29, 2016 – Industry Standard Research (ISR) today announced a new addition to its Department Models and Structures suite of reports.  The new report aims to provide…
Brandon Allison
Fewer European Prescribers Trust Information Received from Telephone Details than Web-based, In-person Details according to ISR’s New Report Press

Fewer European Prescribers Trust Information Received from Telephone Details than Web-based, In-person Details according to ISR’s New Report

Informing the pharmaceutical drug development, manufacturing and commercialization industry Cary, NC – February 23, 2016 – Industry Standard Research (ISR) today announced the release of their “Electronic Detailing in Europe: Value and Outcomes” report.  With this report, ISR investigates the…
Brandon Allison
2016 CMO Leadership Awards to be announced in Life Science Leader’s March 2016 special supplement Press

2016 CMO Leadership Awards to be announced in Life Science Leader’s March 2016 special supplement

ISR's research will power the CMO Leadership Awards Cary, NC – January 1, 2016 –Life Science Leader (lifescienceleader.com) and Industry Standard Research (ISRreports.com) today announced a publisher-market research partnership, where Industry Standard Research (ISR) will serve as the data collection engine behind…
Brandon Allison
GSW, Saatchi & Saatchi Healthcare among Top Ranked Healthcare Ad Agencies in ISR’s New Report Press

GSW, Saatchi & Saatchi Healthcare among Top Ranked Healthcare Ad Agencies in ISR’s New Report

Cary, N.C. – November 11, 2015 - Industry Standard Research (ISR) today announced the release of their newest report “Healthcare Advertising Agency Quality Benchmarking (2015).” In this report, 103 decision-makers who work with ad agencies provided insight into their experiences…
Brandon Allison
Pfizer CentreSource Lands a Top 3 Position Across All 4 CMO Scorecards in ISR’s Latest Contract Manufacturer Quality Benchmarking Report Press

Pfizer CentreSource Lands a Top 3 Position Across All 4 CMO Scorecards in ISR’s Latest Contract Manufacturer Quality Benchmarking Report

Cary, N.C. – June 9, 2015 - Industry Standard Research (ISR) today announced the availability of the “Contract Manufacturer Quality Benchmarking (2015)” report, providing a comprehensive assessment of CMO service quality. This report provides a Consumer Reports-style analysis of CMO…
Brandon Allison
MPI Research, BioReliance among top performers in ISR’s inaugural Preclinical CRO Quality Benchmarking Study Press

MPI Research, BioReliance among top performers in ISR’s inaugural Preclinical CRO Quality Benchmarking Study

Informing the drug development and commercialization industry Cary, N.C. – January 28, 2015 - Industry Standard Research (ISR) has announced the availability of a new report titled, “CRO Quality Benchmarking – Preclinical Service Providers.” This report provides a Consumer Reports-style…
Brandon Allison
DCRI Receives Top Customer Loyalty Scores in ISR’s 6th Annual CRO Quality Benchmarking Study Press

DCRI Receives Top Customer Loyalty Scores in ISR’s 6th Annual CRO Quality Benchmarking Study

Informing the Pharmaceutical Drug Development and Commercialization Industry. Cary, N.C. – March 19, 2014 – Industry Standard Research (ISR) is announcing the launch of its 6th annual CRO Quality Benchmarking series with today's release of its "CRO Quality Benchmarking - Phase II/III…
Brandon Allison
New ISR Report Provides Insight into CMO Service Quality, DSM among the Top 3 in Each Attribute Category Press

New ISR Report Provides Insight into CMO Service Quality, DSM among the Top 3 in Each Attribute Category

Informing the pharmaceutical drug development and commercialization industry. Cary, N.C. – March 12, 2014 – Industry Standard Research (ISR) today announced the availability of a new report titled “Contract Manufacturer Quality Benchmarking (2014),” providing a comprehensive assessment of CMO service…
Brandon Allison
New ISR Report Uncovers Significant Clinical Development Activity, Opportunity in Brazilian Market Press

New ISR Report Uncovers Significant Clinical Development Activity, Opportunity in Brazilian Market

Informing the pharmaceutical drug development and commercialization industry. Cary, N.C. – February 20, 2014 – Industry Standard Research (ISR) released a new market research report this week entitled “Brazil: Clinical Development Country Profile.” The report provides insight into the clinical trial environment…
Brandon Allison
ISR’s Brain Cancer (Glioblastoma Multiforme) Report Analyzes Market Opportunity, Product Pipelines Press

ISR’s Brain Cancer (Glioblastoma Multiforme) Report Analyzes Market Opportunity, Product Pipelines

Informing the pharmaceutical drug development and commercialization industry. Cary, N.C. – February 19, 2013 – Industry Standard Research (ISR) today announced the release of a new market research report titled “Brain Cancer (Glioblastoma Multiforme): Disease and Pipeline Analysis,” offering the…
Brandon Allison
United Biosource Corporation (UBC) Receives High Marks for Staff Quality According to ISR Report Press

United Biosource Corporation (UBC) Receives High Marks for Staff Quality According to ISR Report

Informing the pharmaceutical drug development and commercialization industry. Cary, N.C. – January 6, 2013 – Industry Standard Research (ISR) has announced the availability of a new report titled “2013 CRO Quality Benchmarking – Phase IV Service Providers.”  This study surveyed…
Brandon Allison
New ISR Report Uncovers Significant Clinical Development Activity, Opportunity in South Korean Market Press

New ISR Report Uncovers Significant Clinical Development Activity, Opportunity in South Korean Market

Informing the drug development and commercialization industry Cary, N.C. – June 27, 2013 – Industry Standard Research (ISR) released a new market research report this week entitled “South Korea: Clinical Development Country Profile.” The report provides insight into the clinical…
Brandon Allison
ISR Reviews Report “Risk-based Monitoring: Industry Guidance on Adoption, Use, and Outsourcing” News

ISR Reviews Report “Risk-based Monitoring: Industry Guidance on Adoption, Use, and Outsourcing”

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com’s: ISR Reviews Report "Risk-based Monitoring: Industry Guidance on Adoption, Use, and Outsourcing" https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/ISR-Reviews-Report-Risk-based-Monitoring-Industry-/ArticleStandard/Article/detail/816364
Brandon Allison
ISR Reports: Significant Opportunity Remains for Optimizing Clinical Trials by Using Electronic Medical Records Press

ISR Reports: Significant Opportunity Remains for Optimizing Clinical Trials by Using Electronic Medical Records

Informing the drug development and commercialization industry Cary, N.C. – June 20, 2013 – Industry Standard Research (ISR) today announced the release of a new market research report titled “EMRs and Clinical Research: Current and Potential Impact.” This report provides…
Brandon Allison
ISR Report Provides Medical Device Industry with Analysis of Historical Trials, Development Market Size, and Manufacturer Profiles Press

ISR Report Provides Medical Device Industry with Analysis of Historical Trials, Development Market Size, and Manufacturer Profiles

Informing the drug development and commercialization industry Cary, N.C. – April 3, 2013 – Industry Standard Research (ISR) announced the release of a new market research report entitled “Medical Device: Clinical Development Market Assessment,” which provides the medical device industry…
Brandon Allison
ISR in the News: 2013 Late Phase Market Overview and Outlook News

ISR in the News: 2013 Late Phase Market Overview and Outlook

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com's: "ISR Reports Breaks Down: 2013 Late Phase Market Overview and Outlook" https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/ISR-Reports-Breaks-Down-2013-Late-Phase-Market-Ove/ArticleStandard/Article/detail/807543
Brandon Allison
ISR’s “Social Media: Best Practices and Strategic Use in Patient Recruitment” News

ISR’s “Social Media: Best Practices and Strategic Use in Patient Recruitment”

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com's: "ISR's 'Social Media: Best Practices and Strategic Use in Patient Recruitment'" https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/ISRs-Social-Media-Best-Practices-and-Strategic-Use/ArticleStandard/Article/detail/802212
Brandon Allison
ISR’s Hepatitis C Market Analysis Shows a Deep Pipeline, Uncovers Lack of Internet Search Visibility for Current Therapies Press

ISR’s Hepatitis C Market Analysis Shows a Deep Pipeline, Uncovers Lack of Internet Search Visibility for Current Therapies

Informing the pharmaceutical and biotech industry. Cary, N.C. – October 9, 2012 – Industry Standard Research (ISR) today announced the availability of their latest report, “Hepatitis C: Social Media, Search, and Market Analysis,” providing a product and pipeline analysis of…
Brandon Allison
ISR Reports: Sponsors Indicate a Shift Towards Central Labs in Emerging Markets, Asia Press

ISR Reports: Sponsors Indicate a Shift Towards Central Labs in Emerging Markets, Asia

Informing the pharmaceutical and biotech industry. Cary, N.C. – October  2, 2012 – Industry Standard Research (ISR) today announced the availability of their newest clinical development trends report, “Central Lab Market Dynamics and Outsourcing Performance,” which provides an in-depth analysis…
Brandon Allison
Optimizing Investigator Fees News

Optimizing Investigator Fees

Normal 0 false false false EN-US X-NONE X-NONE ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com's: "Optimizing Investigator Fees" https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Data+Analysis/Optimizing-Investigator-Fees/ArticleStandard/Article/detail/800011 I’m not sure if it’s just me,…
Brandon Allison
ISR Study Finds That INC Research Delivers CRO Industry’s Most Consistent Service Quality Press

ISR Study Finds That INC Research Delivers CRO Industry’s Most Consistent Service Quality

Informing the drug development and commercialization industry Cary, N.C. – February 28, 2012 – Industry Standard Research (ISR) today announced the availability of its 4th annual CRO Quality Benchmarking Report.  The 2012 version released Tuesday includes 125 pharmaceutical and biotechnology…
Brandon Allison